stroke Clinical Trials and Research
Also known as: brain attack, cerebrovascular accident, cva, ischemic stroke, hemorrhagic stroke, mini-stroke, tia · ICD-10: I60-I69
A stroke occurs when blood flow to part of the brain is stopped, causing brain cells to die. Clinical trial research aims to develop new ways to prevent strokes, minimize brain damage during a stroke, and improve long-term recovery for survivors. Find a Trial helps patients search for active studies.
Common questions about stroke clinical trials
What are the different phases of stroke clinical trials?
Clinical trials typically progress through phases 1 to 4. Early phases test safety and dosage in small groups, while later phases evaluate effectiveness and monitor side effects in larger patient populations. This structured approach helps ensure new treatments are safe and effective. Data from ClinicalTrials.gov.
Do stroke clinical trials cost money to participate in?
Generally, participants do not pay for the experimental treatment or study-related medical care in a clinical trial. However, some routine medical costs or travel expenses might not be covered. Patients should always clarify financial details with the study team. Data from ClinicalTrials.gov.
What are current research directions in stroke clinical trials?
Current research focuses on improving acute stroke treatments, such as new clot-busting drugs or devices for clot removal. Other areas include neurorehabilitation strategies, stem cell therapies for recovery, and better prevention methods for recurrent strokes. Data from ClinicalTrials.gov and NIH RePORTER.
What types of interventions are studied in stroke clinical trials?
Interventions range from new medications to improve blood flow or protect brain cells, to innovative surgical techniques, and advanced physical or occupational therapies. Studies also explore lifestyle modifications and technology-assisted rehabilitation tools. Data from ClinicalTrials.gov and NIH RePORTER.
Are there specific biomarkers important in stroke clinical trials?
Researchers are investigating various biomarkers, including genetic markers, blood proteins, and imaging findings, to predict stroke risk, severity, and response to treatment. These markers could help personalize care and identify patients most likely to benefit from specific interventions. Data from NIH RePORTER.
What are common reasons someone might be excluded from a stroke clinical trial?
Common exclusion criteria can include pre-existing conditions like severe heart disease, certain types of prior brain injury, or recent major surgery. Other factors might be an inability to provide informed consent or participation in another clinical study. Data from ClinicalTrials.gov.
How do clinical trials address stroke recovery?
Many trials focus on enhancing recovery through novel rehabilitation approaches, such as robot-assisted therapy, virtual reality, or brain stimulation techniques. Others investigate drugs or biological therapies aimed at promoting brain repair and functional restoration after a stroke. Data from ClinicalTrials.gov and NIH RePORTER.
How to find a stroke trial that fits you
- Describe your stroke situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.